Nimesulide & Paracetamol Tablet Franchise in Ahmedabad

Pain & Fever Relief Tablet Supplier in Mumbai

Nimoplit P 500 Tablet Distributor in Delhi

Analgesic & Anti-Inflammatory Tablet Franchise Opportunity in Bangalore

Musculoskeletal Pain Relief Tablet Stockist in Hyderabad
Nimesulide Paracetamol Export & Manufacturing in Chandigarh

Home/Products /nimesulide-100mg-paracetamol-500mg-tablet

Nimoplit P 500 Tablet

Composition : Nimesulide (100mg) + Paracetamol (500mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Nimoplit P 500 Tablet contains Nimesulide 100mg + Paracetamol 500mg, a widely used combination for effective relief from pain, inflammation, and fever. It is commonly prescribed in conditions such as musculoskeletal pain, dental pain, post-operative discomfort, and acute febrile illnesses.

Nimesulide provides anti-inflammatory and analgesic action by inhibiting prostaglandin synthesis, while Paracetamol enhances pain relief and reduces fever through central action. Together, they offer rapid and sustained symptom control with good patient compliance.

For distributors and healthcare suppliers, Nimoplit P 500 Tablet is a high-rotation analgesic medicine, regularly recommended by general physicians, orthopedic specialists, and dentists. Continuous demand for pain and fever management therapies ensures consistent market movement.

Adding Nimoplit P 500 Tablet to your pain management and general medicine segment creates strong opportunities in retail pharmacies, hospitals, clinics, export markets, and third-party manufacturing. Its reliable efficacy, broad therapeutic application, and strong prescriber acceptance make it a valuable addition to pharmaceutical distribution portfolios.


Read More

About the Product

Nimoplit P 500 Tablet contains Nimesulide 100mg + Paracetamol 500mg, a widely used combination for effective relief from pain, inflammation, and fever. It is commonly prescribed in conditions such as musculoskeletal pain, dental pain, post-operative discomfort, and acute febrile illnesses.

Nimesulide provides anti-inflammatory and analgesic action by inhibiting prostaglandin synthesis, while Paracetamol enhances pain relief and reduces fever through central action. Together, they offer rapid and sustained symptom control with good patient compliance.

For distributors and healthcare suppliers, Nimoplit P 500 Tablet is a high-rotation analgesic medicine, regularly recommended by general physicians, orthopedic specialists, and dentists. Continuous demand for pain and fever management therapies ensures consistent market movement.

Adding Nimoplit P 500 Tablet to your pain management and general medicine segment creates strong opportunities in retail pharmacies, hospitals, clinics, export markets, and third-party manufacturing. Its reliable efficacy, broad therapeutic application, and strong prescriber acceptance make it a valuable addition to pharmaceutical distribution portfolios.


Common side effects may include nausea, vomiting, abdominal discomfort, heartburn, or diarrhea. Rare but serious side effects include liver toxicity, allergic reactions, or gastrointestinal bleeding. Patients should seek medical attention if severe abdominal pain, jaundice, or persistent symptoms occur.

Nimoplit P 500 Tablet is indicated for the treatment of acute pain, fever, inflammatory conditions, headache, toothache, musculoskeletal pain, post-operative pain, and painful inflammatory disorders.

Nimoplit P 500 Tablet should be taken strictly as prescribed by a healthcare professional and is generally recommended for short-term use only. Patients with liver disease, gastrointestinal disorders, or known hypersensitivity to NSAIDs or Paracetamol should inform their doctor before use. Avoid alcohol consumption during treatment.

Store Nimoplit P 500 Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and ensure the blister pack is intact. Do not use the tablet beyond the expiry date mentioned on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation